June 30, 2026 Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
June 30, 2026 ArcelorMittal announces commencement of the second tranche of its 2025 to 2030 share buyback programme
June 30, 2026 Globavend Releases First Fully AI-Produced Original Micro Drama, Entering a US$11 Billion Global Market
All HIV medicines on these platforms should be considered suspect products
All HIV medicines on these platforms should be considered suspect products 
